Second Sight Medical (NASDAQ: EYES) reported Q4 Adj. EPS ex-items of ($0.17), in-line with the analyst estimate of ($0.17). Revenue for the quarter came in at $715 thousand, versus $2.4 million reported last year.

For earnings history and earnings-related data on Second Sight Medical (EYES) click here.